Associate Professor of Clinical Pharmacy

Pharmacoeconomics

Mark Bounthavong Photo
Mark Bounthavong, Pharm.D., Ph.D.

Associate Professor of Clinical Pharmacy

Skaggs School of Pharmacy and Pharmaceutical Sciences

     

    Email
    mbounthavong@health.ucsd.edu
    Phone
    (858) xxx-xxxx
    Research Summary

    Dr. Bounthavong’s research interests include pharmacoeconomics, program and implementation evaluations, applied econometrics, and evidence-synthesis using Bayesian methods. More recently, Dr. Bounthavong’s research has centered around evaluating academic detailing’s impact on aligning provider’s behavior with evidence-based practice, particularly with the opioid epidemic.

    Academic Achievements

    Education

    • B.S. in Biological Sciences (1999) University of California, Irvine
    • PharmD (2004) Western University of Health Sciences College of Pharmacy
    • PGY1 Pharmacy Practice Residency (2005) VA Loma Linda Medical Center
    • Pharmacoeconomics and Outcomes Research Fellowship (2007) Western University of Health Sciences College of Pharmacy
    • Master of Public Health (2013) Emory University Rollins School of Public Health
    • PhD (2018) University of Washington, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

    Awards and Honors

    • Best Paper Award (2018) Vancouver Health Economics Methodology Meeting, Vancouver, Canada
    • U.S. Under Secretary of Health Pharmacy Practice Innovation Award (2009, 2017), U.S. Department of Veterans Affairs
    • American Society of Health-System Pharmacists Best Practice Award (2009, 2017)
    • Alumni Achievement Award (2016) 20th Anniversary Gala Celebration. College of Pharmacy, Western University of Health Sciences
    • AHRQ T32 Fellowship (2013-2015) Agency for Healthcare Research and Quality T32 PhD Student training grant#T32HS013853
    • American Society of Health-System Pharmacists Literature (Best Paper) Award (2010)
    • Distinguish Service Award (2009) Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific

    Leadership Experience

    • Associate Editor (2020) Substance Abuse journal (SAj) Print ISSN: 0889-7077 Online ISSN: 1547-0164
    • Chair (2019-present) Pharmacy Evaluation-Research Selection Committee, VA Pharmacy Benefits Management Academic Detailing Service
    • Steering Committee Member (2018-present) New Professions Steering Committee, International Society for Pharmacoeconomics and Outcomes Research
    • Director, PGY1 Managed Care Pharmacy Residency (2008-2013) Veterans Affairs San Diego Healthcare System
    Teaching

    Pharmacy: Applied Pharmacoeconomics SPPS 209

    Pharmacy: Study Design and Biostatistics SPPS 206

    Key Contributions
    • Published data used by the U.S. Office of the Inspector General’s Report on the opioid crisis
    • Implemented and maintained the first pharmacist-run immunization clinic at the Veterans Health Administration
    • Developed national formulary monographs for VA Pharmacy Benefits Management
    • Contributed (economic analysis) to the establishment of the first emergency department pharmacist position at the Veterans Health Administration
    Selected Publications

    Bounthavong M, Lau MK, Popish SJ, et al. Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. Subst Abus. 2020;41(1):101-109. doi:10.1080/08897077.2019.1573777

    Bounthavong M, Devine EB, Christopher MLD, Harvey MA, Veenstra DL, Basu A. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. Health Serv Res. 2019;54(5):1055-1064. doi:10.1111/1475-6773.13194

    Bounthavong M, Butler J, Dolan CM, et al. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. Pharmacoeconomics. 2018;36(12):1463-1473. doi:10.1007/s40273-018-0709-3

    Bounthavong M, Harvey MA, Wells DL, et al. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. J Am Pharm Assoc (2003). 2017;57(2S):S68-S72. doi:10.1016/j.japh.2016.11.003.

    Aldridge VE, Park HK, Bounthavong M, Morreale AP. Implementing a comprehensive, 24-hour emergency department pharmacy program. Am J Health Syst Pharm. 2009;66(21):1943-1947. doi:10.2146/ajhp080660.